Efficacy and Safety of Bitopertin in Patients with Schizophrenia and Predominant Negative Symptoms: Subgroup Analysis of Japanese Patients from the Global Randomized Phase 2 Trial
Yoshio Hirayasu, Shin-Ichi Sato, Norifumi Shuto, Miwa Nakano, Teruhiko Higuchi
Psychiatry Investig. 2017;14(1):63-73.   Published online 2016 Dec 29     DOI: https://doi.org/10.4306/pi.2017.14.1.63
Categorizing and assessing negative symptoms
Paola Bucci, Silvana Galderisi
Current Opinion in Psychiatry.2017; 30(3): 201.     CrossRef